China's pharmaceutical and hospital infrastructure for Actinium-225 PSMA radioligand therapy is expanding rapidly. However, macroscopic manufacturing capacity does not equal automatic patient access. Navigating the complex nuclear medicine protocols, specialized isolation wards, and S2 medical visa requirements requires precise administrative expertise.

In our latest guide, we break down the administrative realities of Medical Tourism China for advanced oncology patients. As a professional medical concierge provider, MedBridgeNZ Limited does not provide medical advice or treatment. Instead, we coordinate the complex logistics—from clinical record translation to hospital liaison services—ensuring your case is properly formatted for multidisciplinary review by licensed Chinese institutions.

Discover the step-by-step administrative pathway and pre-review record checklist here: Actinium-225 PSMA Access in China for mCRPC: What International Patients Should Know

Device built for extreme environment could speed Actinium-225 production

Chemist Kevin Gaddis has adapted components of a high pressure ion chromatography system to withstand the extreme conditions of a hot cell. The pump-driven system could cut the time needed for isotope separations by 75%. Credit: Carlos Jones/ ORNL, U.S. Dept. of Energy High pressure ion chromatography—using a high-pressure pump to enable more rapid separation of ions—is one of the fastest and…